U.S. markets open in 10 minutes
  • S&P Futures

    4,240.25
    +4.00 (+0.09%)
     
  • Dow Futures

    33,893.00
    +58.00 (+0.17%)
     
  • Nasdaq Futures

    14,265.50
    +7.25 (+0.05%)
     
  • Russell 2000 Futures

    2,293.90
    +1.40 (+0.06%)
     
  • Crude Oil

    73.63
    +0.78 (+1.07%)
     
  • Gold

    1,783.60
    +6.20 (+0.35%)
     
  • Silver

    25.98
    +0.12 (+0.48%)
     
  • EUR/USD

    1.1957
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.4840
    +0.0120 (+0.82%)
     
  • Vix

    16.35
    -1.54 (-8.61%)
     
  • GBP/USD

    1.3988
    +0.0040 (+0.29%)
     
  • USD/JPY

    110.8820
    +0.2470 (+0.22%)
     
  • BTC-USD

    34,016.28
    +2,401.55 (+7.60%)
     
  • CMC Crypto 200

    813.96
    +19.63 (+2.47%)
     
  • FTSE 100

    7,124.60
    +34.59 (+0.49%)
     
  • Nikkei 225

    28,874.89
    -9.24 (-0.03%)
     

Pfizer's Hospira To Call Back Hospital Anesthetics Due To Mislabeling

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Pfizer’s Inc (NYSE: PFE) Hospira will recall one lot of each of the injectable hospital anesthetics bupivacaine hydrochloride (HCL) and lidocaine HCL following an investigation revealing that a portion of each lot was mislabeled as the other product.

  • Hospira’s assessment of the potential risk to patients concluded that the use of the impacted product is likely to cause adverse events of moderate to high severity.

  • If a patient were to receive 1% lidocaine instead of 0.5% bupivacaine, they could be underdosed, potentially leading to subpar pain management and failure of surgical anesthesia, Hospira said.

  • On the other hand, a patient who receives an affected bupivacaine dose in place of lidocaine could overdose, which could cause seizures, low oxygen and-or elevated carbon dioxide levels in the blood, and more.

  • Hospira said a bupivacaine overdose could also lead to cardiovascular issues like irregular heartbeat, cardiac arrest, and cardiac flatline.

  • The products were shipped across the U.S., Puerto Rico, and Guam between December 29, 2020, and April 15, 2021.

  • The bupivacaine lot was due to expire in July 2022, while the lidocaine batch was good until August 2022.

  • On that front, Pfizer is also building a new $450 million sterile injectables facility in Portage, Michigan, dubbed as its Modular Aseptic Processing (MAP) facility.

  • Price Action: PFE shares are trading 1.6% higher at $40.62 during the market session on the last check Wednesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.